Positive News SentimentPositive NewsNYSE:CHE Chemed (CHE) Stock Price, News & Analysis $615.19 +9.49 (+1.57%) Closing price 03:59 PM EasternExtended Trading$614.40 -0.79 (-0.13%) As of 04:11 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Stock Analysis Stock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock About Chemed Stock (NYSE:CHE) 30 days 90 days 365 days Advanced Chart View Price History Chart DataSkip Price History Chart Get Chemed alerts:Sign Up Key Stats Today's Range$607.45▼$620.0050-Day Range$542.80▼$615.1952-Week Range$512.12▼$642.68Volume116,086 shsAverage Volume93,654 shsMarket Capitalization$9.00 billionP/E Ratio31.09Dividend Yield0.33%Price Target$667.00Consensus RatingBuy Company OverviewChemed Corporation provides hospice and palliative care services to patients through a network of physicians, registered nurses, home health aides, social workers, clergy, and volunteers primarily in the United States. The company operates in VITAS and Roto-Rooter segments. It offers plumbing, drain cleaning, excavation, water restoration, and other related services to residential and commercial customers through company-owned branches, independent contractors, and franchisees. The company was incorporated in 1970 and is headquartered in Cincinnati, Ohio.Read More… Remove Ads Chemed Stock Analysis - MarketRank™See Top-Rated MarketRank™ Stocks89th Percentile Overall ScoreCHE MarketRank™: Chemed scored higher than 89% of companies evaluated by MarketBeat, and ranked 104th out of 932 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation. Analyst's Opinion1.5 / 5Analyst RatingBuy Consensus RatingChemed has received a consensus rating of Buy. The company's average rating score is 3.00, and is based on 1 buy rating, no hold ratings, and no sell ratings.Amount of Analyst CoverageChemed has only been the subject of 1 research reports in the past 90 days.Read more about Chemed's stock forecast and price target. Earnings and Valuation1.3 / 5Proj. Earnings Growth8.73% Earnings GrowthEarnings for Chemed are expected to grow by 8.73% in the coming year, from $21.43 to $23.30 per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of Chemed is 31.09, which means that it is trading at a more expensive P/E ratio than the market average P/E ratio of about 22.45.Price to Earnings Ratio vs. SectorThe P/E ratio of Chemed is 31.09, which means that it is trading at a more expensive P/E ratio than the Medical sector average P/E ratio of about 23.63.Price to Earnings Growth RatioChemed has a PEG Ratio of 2.15. PEG Ratios above 1 indicate that a company could be overvalued.Price to Book Value per Share RatioChemed has a P/B Ratio of 8.36. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.Read more about Chemed's valuation and earnings. Short Interest4.0 / 5Short Interest LevelHealthy Percentage of Shares Shorted2.02% of the float of Chemed has been sold short.Short Interest Ratio / Days to CoverChemed has a short interest ratio ("days to cover") of 2.7, which is generally considered an acceptable ratio of short interest to trading volume.Change versus previous monthShort interest in Chemed has recently decreased by 2.46%, indicating that investor sentiment is improving. Dividend3.3 / 5Dividend StrengthStrong Dividend YieldChemed has a dividend yield of 0.33%, which is in the bottom 25% of all stocks that pay dividends.Dividend GrowthChemed has been increasing its dividend for 16 years.Dividend CoverageThe dividend payout ratio of Chemed is 10.05%. This payout ratio is at a healthy, sustainable level, below 75%.Dividend SustainabilityBased on earnings estimates, Chemed will have a dividend payout ratio of 8.58% next year. This indicates that Chemed will be able to sustain or increase its dividend.Read more about Chemed's dividend. Sustainability and ESG4.9 / 5Environmental Score-0.33 Percentage of Shares Shorted2.02% of the float of Chemed has been sold short.Short Interest Ratio / Days to CoverChemed has a short interest ratio ("days to cover") of 2.7, which is generally considered an acceptable ratio of short interest to trading volume.Change versus previous monthShort interest in Chemed has recently decreased by 2.46%, indicating that investor sentiment is improving. News and Social Media3.7 / 5News Sentiment1.65 News SentimentChemed has a news sentiment score of 1.65. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.82 average news sentiment score of Medical companies.News Coverage This WeekMarketBeat has tracked 11 news articles for Chemed this week, compared to 7 articles on an average week.Search Interest2 people have searched for CHE on MarketBeat in the last 30 days. Company Ownership2.5 / 5Insider TradingSelling Shares Insider Buying vs. Insider SellingIn the past three months, Chemed insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $1,187,340.00 in company stock.Percentage Held by InsidersOnly 3.32% of the stock of Chemed is held by insiders.Percentage Held by Institutions95.85% of the stock of Chemed is held by institutions. High institutional ownership can be a signal of strong market trust in this company.Read more about Chemed's insider trading history. Receive CHE Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Chemed and its competitors with MarketBeat's FREE daily newsletter. Email Address CHE Stock News HeadlinesChemed Co. (NYSE:CHE) CEO Sells $1,187,340.00 in StockMarch 8, 2025 | insidertrades.com2 Healthcare Stocks with Solid Fundamentals and 1 to Brush OffMarch 18, 2025 | msn.comDo this Before Elon's Reveal on April 23rdElon’s newest tech could pay you an extra $30,000 a year — while you sleep. It’s smaller than a quarter but designed to power a $9 trillion AI revolution. And I’ve identified a little-known supplier Elon is depending on to make it all happen.March 31, 2025 | Brownstone Research (Ad)RBC Capital Sticks to Its Buy Rating for Chemed (CHE)March 14, 2025 | markets.businessinsider.comChemed price target raised to $667 from $633 at RBC CapitalMarch 14, 2025 | markets.businessinsider.comChemed (NYSE:CHE) Might Become A Compounding MachineMarch 8, 2025 | finance.yahoo.comChemed Shows Improved Relative Strength; Still Shy Of BenchmarkMarch 8, 2025 | msn.comChemed CEO’s Major Stock Sale: What It Means for the CompanyMarch 7, 2025 | tipranks.comSee More Headlines CHE Stock Analysis - Frequently Asked Questions How have CHE shares performed this year? Chemed's stock was trading at $529.80 at the start of the year. Since then, CHE shares have increased by 16.1% and is now trading at $615.1870. View the best growth stocks for 2025 here. How were Chemed's earnings last quarter? Chemed Co. (NYSE:CHE) issued its quarterly earnings data on Tuesday, October, 29th. The company reported $5.64 earnings per share for the quarter, missing analysts' consensus estimates of $5.76 by $0.12. Chemed's quarterly revenue was up 7.4% compared to the same quarter last year. Who are Chemed's major shareholders? Chemed's top institutional shareholders include Vanguard Group Inc. (11.09%), Kayne Anderson Rudnick Investment Management LLC (3.87%), Kayne Anderson Rudnick Investment Management LLC (3.87%) and Neuberger Berman Group LLC (3.33%). Insiders that own company stock include Kevin J Mcnamara, Spencer S Lee, David Patrick Williams, Nicholas Michael Westfall, Andrea R Lindell, Donald E Saunders, Patrick P Grace, George J Walsh III, Michael D Witzeman and Brian C Judkins. View institutional ownership trends. How do I buy shares of Chemed? Shares of CHE stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. What other stocks do shareholders of Chemed own? Based on aggregate information from My MarketBeat watchlists, some other companies that Chemed investors own include Humana (HUM), American Water Works (AWK), Waste Connections (WCN), Voyager Therapeutics (VYGR), The RMR Group (RMR), DiamondRock Hospitality (DRH) and AUO (AUOTY). Company Calendar Last Earnings10/29/2024Record date for 3/14 Dividend2/24/2025Ex-Dividend for 3/14 Dividend2/24/2025Dividend Payable3/14/2025Today3/31/2025Next Earnings (Estimated)4/23/2025Fiscal Year End12/31/2025Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNYSE SectorMedical Industry Home health care services Sub-IndustryHealth Care Services Current SymbolNYSE:CHE CIK19584 Webwww.chemed.com Phone(513) 762-6690Fax513-762-6590Employees14,200Year Founded1970Price Target and Rating Average Stock Price Target$667.00 High Stock Price Target$667.00 Low Stock Price Target$667.00 Potential Upside/Downside+8.8%Consensus RatingBuy Rating Score (0-4)3.00 Research Coverage1 Analysts Profitability EPS (Most Recent Fiscal Year)$19.91 Trailing P/E Ratio30.98 Forward P/E Ratio28.61 P/E Growth2.15Net Income$272.51 million Net Margins12.69% Pretax Margin16.61% Return on Equity27.86% Return on Assets19.12% Debt Debt-to-Equity RatioN/A Current Ratio1.85 Quick Ratio1.81 Sales & Book Value Annual Sales$2.43 billion Price / Sales3.69 Cash Flow$27.37 per share Price / Cash Flow22.40 Book Value$73.55 per share Price / Book8.34Miscellaneous Outstanding Shares14,637,000Free Float14,550,000Market Cap$8.97 billion OptionableOptionable Beta0.43 Social Links Metaverse Stocks And Why You Can't Ignore ThemThinking about investing in Meta, Roblox, or Unity? Enter your email to learn what streetwise investors need to know about the metaverse and public markets before making an investment.Get This Free Report This page (NYSE:CHE) was last updated on 3/31/2025 by MarketBeat.com Staff From Our PartnersA brutally honest economic warning for 2025 (see proof)New York Times best-selling financial author and world-renowned economist Addison Wiggin (a man who’s worked s...Banyan Hill Publishing | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredHas Trump finally met his match?Dylan Jovine predicted the 2008 crash over a year before it happened. Folks who listened to him had the chance...Behind the Markets | SponsoredJust Revealed: The chip company making AI look primitiveIn his just-released video presentation, this renowned market strategist — who's been called "one of the most ...InvestorPlace | SponsoredDOGE officially begins retirement transformationElon Musk's Department of Government Efficiency ("DOGE") just announced the first-ever "fully digital retireme...Altimetry | SponsoredUrgent Bitcoin alert for RIGHT NOWFormer billion-dollar hedge fund manager Larry Benedict has released the most incredible presentation of his 4...Brownstone Research | Sponsored“Amazon Coin” set to outperform BitcoinChris Rowe – the man who recommended Amazon in 1998… Bitcoin and Ethereum in 2017… And has spotted 44 diffe...True Market Insiders | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Chemed Co. Please log in to your account or sign up in order to add this asset to your watchlist. Share Chemed With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.